Trump was elected as the new US president and said in a television interview that he would abolish Obama’s medical reform and introduce a replacement bill. But for Obama's precision medicine program, Trump has not expressed his views in public. Many insiders have doubts about whether the new president has an impact on precision medical planning.
Recently, during the 6th Bio4P Precision Medical Innovation Forum, Yu Jun, a researcher at the Beijing Institute of Genomics of the Chinese Academy of Sciences and founder of Huada Gene, said in an interview that Trump’s appointment to the US’s precision medicine program could not have an impact.
However, there are also different views. After Trump took office, the budget for investing in scientific research in the United States will fall. The precision medical plan and the cancer landing plan are the plans of the previous president. The next time, the amount and time of funding May have an impact.
Trump
Gene Tao today comes back to the US precision medicine program, the progress of the recent year and the possible future direction.
What exactly is the precision medicine program?
On January 30, 2015, Obama announced a new plan in the State of the Union address speech, the Precision Medicine Program. He said that this plan will allow us to move toward the goal of curing chronic diseases such as cancer and diabetes, and to enable us all to obtain our own personalized information. We need this information to make ourselves and our family healthier.
As a technology superpower in the United States, the contribution to life sciences and medical clinics has been numerous for more than a century, but Obama’s think tank has given him only two contributions: the eradication of polio and the initial completion of the Human Genome Project. . The proposal for precision medicine is a continuation of the Human Genome Project.
Ten days after Obama proposed the Precision Medicine Program, he announced the specific content of the Precision Medicine Program. The first was to launch the Million Human Genome Project. First, we need to collect 1 million volunteers and do a cohort and control to establish “unprecedented big data†related to the clinic, collecting genomic data and clinical information.
The second is to look for genetic factors that trigger cancer, that is, to continue the cancer genome research program that the United States has begun, namely the TCGA (The Cancer Genome Altas) program. The third is to establish new methods for assessing genetic testing, especially for the evaluation and approval of next-generation sequencing technologies, as well as the protection of intellectual property rights and related copyright management to ensure the demand for precision medicine and related innovations. The fourth is to develop a series of relevant standards and policies. From the first day, efforts must be made to protect personal privacy and the security of various data. The fifth is the PPP (Public-Private-Partnership) approach, inviting entrepreneurs and non-profit organizations to participate.
Barrier Mesh,Plastic Fence Mesh,Insect Barrier Netting,Agfabric Insect Netting
Changzhou Satidi Import and Export Co., Ltd. , https://www.czguanjiechuck.com